This inventor holds 1 USPTO granted patent. Top assignee: Gwangju Institute of Science and Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Young Hwan Jung: Innovator in Pharmaceutical Compounds
Introduction: Young Hwan Jung is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in chronic inflammatory diseases and neuropathic pain.
Latest Patents: Young Hwan Jung holds a patent for a novel 5-hydroxy pyridine-based compound. This compound is designed for use as a P2X1 and P2X3 receptor antagonist. The patent describes the compounds as having strong antagonistic activity against P2X1 and P2X3 receptors, making them effective for treating or preventing diseases associated with these receptors.
Career Highlights: Young Hwan Jung is affiliated with the Gwangju Institute of Science and Technology, where he conducts research and development in the field of pharmaceutical sciences. His work focuses on creating innovative solutions for complex medical conditions.
Collaborations: Young Hwan Jung collaborates with fellow researcher Yong Chul Kim, contributing to advancements in their shared field of study.
Conclusion: Young Hwan Jung's innovative work in developing receptor antagonists showcases his commitment to improving therapeutic options for patients suffering from chronic inflammatory and neuropathic pain diseases. His contributions are paving the way for future advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile